ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+3.11%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$173M
AUM Growth
+$173M
(-8%)
Cap. Flow
+$374K
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
65.37%
Holding
64
New
5
Increased
20
Reduced
6
Closed
19
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$8.43M |
| 2 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$5.52M |
| 3 |
Veracyte
VCYT
|
$5.51M |
| 4 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$4.93M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$3.91M |
Top Sells
| 1 |
Universal Display
OLED
|
$11.8M |
| 2 |
Incyte
INCY
|
$4.78M |
| 3 |
CRDC
CARDICA INC COM NEW (DE)
CRDC
|
$3.79M |
| 4 |
Exelixis
EXEL
|
$3.55M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.17M |
Sector Composition
| 1 | Healthcare | 71.32% |
| 2 | Technology | 2.19% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amicus Therapeutics
FOLD
$2.34B
| $21.1M | 11.81% | 2,500,000 +997,339 | +66% | +$8.43M |
|
|
2
Veracyte
VCYT
$2.39B
| $14.8M | 8.26% | 2,736,642 +1,020,642 | +59% | +$5.51M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $13.8M | 7.73% | 5,526,172 +1,562,139 | +39% | +$3.91M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $12.7M | 7.1% | 2,500,000 +585,000 | +31% | +$2.97M |
|
|
NDRM
5
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $11.7M | 6.53% | 826,799 +349,499 | +73% | +$4.93M |
|
6
Ascendis Pharma
ASND
$11.8B
| $11.6M | 6.47% | 623,631 +104,388 | +20% | +$1.94M |
|
|
RRM
7
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
| $7.95M | 4.44% | 608,318 +111,091 | +22% | +$1.45M |
|
|
CYNA
8
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $7.03M | 3.93% | 590,530 +213,883 | +57% | +$2.55M |
|
9
IRIDEX
IRIX
$22.8M
| $6.72M | 3.76% | 657,670 +200,670 | +44% | +$2.05M |
|
|
CPXX
10
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $5.52M | 3.08% | +500,000 | New | +$5.52M |
|
|
NBRV
11
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $4.88M | 2.73% | 544,972 +132,225 | +32% | +$1.18M |
|
|
EVDY
12
DELISTED
Everyday Health, Inc.
EVDY
| $4.62M | 2.58% | 824,500 +466,153 | +130% | +$2.61M |
|
|
SBBP
13
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.51M | 2.52% | 1,063,747 +84,840 | +9% | +$359K |
|
|
CASM
14
DELISTED
CAS Medical Systems, Inc.
CASM
| $3.8M | 2.13% | 2,678,753 +126,950 | +5% | +$180K |
|
|
15
Universal Display
OLED
$6.59B
| $3.79M | 2.12% | 70,000 -217,397 | -76% | -$11.8M |
|
|
CEMP
16
DELISTED
Cempra, Inc.
CEMP
| $3.68M | 2.06% | 210,000 -40,000 | -16% | -$701K |
|
17
PDS Biotechnology
PDSB
$57.8M
| $3.52M | 1.97% | 385,100 +226,293 | +142% | +$2.07M |
|
18
Akebia Therapeutics
AKBA
$833M
| $3.48M | 1.95% | +386,308 | New | +$3.48M |
|
|
INNL
19
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $3.24M | 1.81% | 377,765 +57,210 | +18% | +$491K |
|
|
OXFD
20
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.05M | 1.71% | 308,044 +117,944 | +62% | +$1.17M |
|
21
Travere Therapeutics
TVTX
$1.56B
| $2.73M | 1.53% | 200,000 -170,000 | -46% | -$2.32M |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.21M | 1.24% | 103,283 +14,844 | +17% | +$318K |
|
|
ALIM
23
DELISTED
Alimera Sciences, Inc.
ALIM
| $1.71M | 0.95% | 974,318 | – | – |
|
24
Rigel Pharmaceuticals
RIGL
$697M
| $1.62M | 0.9% | 776,842 +320,781 | +70% | +$667K |
|
25
ESSA Pharma
EPIX
$11.4M
| $1.52M | 0.85% | 467,333 +144,833 | +45% | +$472K |
|